UK markets close in 6 hours
  • FTSE 100

    7,010.28
    -8.32 (-0.12%)
     
  • FTSE 250

    17,797.04
    -175.65 (-0.98%)
     
  • AIM

    830.18
    -3.41 (-0.41%)
     
  • GBP/EUR

    1.1108
    -0.0081 (-0.72%)
     
  • GBP/USD

    1.0767
    -0.0090 (-0.82%)
     
  • BTC-GBP

    17,835.13
    +37.65 (+0.21%)
     
  • CMC Crypto 200

    439.62
    -4.91 (-1.10%)
     
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • DOW

    29,590.41
    -486.29 (-1.62%)
     
  • CRUDE OIL

    78.55
    -0.19 (-0.24%)
     
  • GOLD FUTURES

    1,653.90
    -1.70 (-0.10%)
     
  • NIKKEI 225

    26,431.55
    -722.28 (-2.66%)
     
  • HANG SENG

    17,855.14
    -78.13 (-0.44%)
     
  • DAX

    12,306.38
    +22.19 (+0.18%)
     
  • CAC 40

    5,793.31
    +9.90 (+0.17%)
     

Novartis says it is subject of Swiss competition probe

FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

BERLIN (Reuters) - Novartis is the subject of an investigation by the Swiss competition commission into patent use, the Swiss pharmaceutical company said on Thursday.

"Novartis is fully cooperating with authorities and is confident to clarify legitimacy of its position," it said in a statement, adding that the opening of an investigation did not imply any wrongdoing or financial impact.

Novartis will not comment further on the investigation at this time, it added.

(Writing by Miranda Murray; Editing by Michael Shields)